Profile data is unavailable for this security.
About the company
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in EUR (TTM)19.48bn
- Net income in EUR1.19bn
- Incorporated2000
- Employees80.50k
- LocationRoyal PhilipsAmstelplein 2AMSTERDAM 1096 BCNetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
More ▼
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| Medumo Inc | -0.99% | -- |
| Carestream Health Inc-Healthcare Information Systems Business | 8.64% | -- |
Data delayed at least 15 minutes, as of Feb 27 2020 08:48 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GN Store Nord A/S | 1.68bn | 194.57m | 7.42bn | 6.28k | 35.40 | 10.37 | 22.78 | 4.41 | 11.02 | 11.02 | 94.99 | 37.60 | 0.8467 | 4.42 | 4.83 | 2,003,825.00 | 9.89 | 9.11 | 13.54 | 11.67 | 60.30 | 61.65 | 11.67 | 11.53 | 0.9857 | 22.73 | 0.5918 | 16.35 | 18.54 | 11.37 | 17.16 | 12.89 | 7.05 | 10.01 |
| Carl Zeiss Meditec AG | 1.51bn | 169.87m | 8.96bn | 3.23k | 52.90 | -- | -- | 5.95 | 1.89 | 1.89 | 16.81 | -- | -- | -- | -- | 465,773.50 | -- | 8.17 | -- | 10.44 | 57.17 | 54.77 | 11.35 | 9.71 | -- | 9.71 | -- | 38.12 | 13.93 | 9.92 | 26.33 | 16.34 | 20.85 | 10.20 |
| Straumann Holding AG | 1.50bn | 288.32m | 14.36bn | 7.49k | 49.93 | 11.19 | 38.03 | 9.57 | 19.26 | 19.26 | 100.31 | 85.94 | 0.7504 | 1.90 | 4.73 | 213,000.40 | 14.48 | 15.64 | 18.15 | 18.58 | 75.21 | 76.07 | 19.30 | 20.20 | 1.12 | 14.01 | 0.1449 | 32.56 | 17.06 | 17.58 | 12.36 | 14.19 | 51.40 | 8.92 |
| Sonova Holding AG | 2.72bn | 582.63m | 14.69bn | 14.99k | 25.33 | 6.89 | 19.78 | 5.41 | 9.57 | 9.57 | 44.58 | 35.19 | 0.66 | 3.14 | 6.75 | 195,806.30 | 14.30 | 11.32 | 18.49 | 14.01 | 71.25 | 69.25 | 21.66 | 16.27 | 0.7224 | 73.05 | 0.2298 | 41.08 | 4.43 | 7.21 | 13.49 | 5.91 | 4.49 | 8.83 |
| Sartorius Stedim Biotech SA | 1.44bn | 234.47m | 16.69bn | 6.20k | 71.39 | 14.41 | 53.99 | 11.59 | 2.54 | 2.54 | 15.58 | 12.57 | 0.8494 | 2.39 | 6.53 | 232,237.60 | 13.91 | 13.41 | 18.47 | 17.91 | 51.95 | 51.35 | 16.38 | 15.61 | 0.7152 | 24.19 | 0.1031 | 25.94 | 18.84 | 16.08 | 12.75 | 26.49 | 23.64 | 25.70 |
| Smith & Nephew plc | 4.72bn | 551.50m | 19.23bn | 16.00k | 34.97 | 4.07 | 21.95 | 4.07 | 0.5301 | 0.5301 | 4.54 | 4.55 | 0.592 | 0.8893 | 3.89 | -- | 6.91 | 8.41 | 8.37 | 10.22 | 73.96 | 73.89 | 11.68 | 13.50 | 1.03 | 19.00 | 0.2848 | 41.51 | 4.77 | 2.16 | -9.50 | 3.67 | 1.70 | -4.84 |
| Coloplast A/S | 2.45bn | 531.79m | 24.72bn | 12.00k | 50.01 | 36.35 | 39.51 | 10.08 | 18.65 | 18.65 | 86.03 | 25.66 | 1.45 | 3.14 | 6.24 | 1,518,138.00 | 31.37 | 27.20 | 64.06 | 47.22 | 67.99 | 67.96 | 21.68 | 19.82 | 0.6685 | 36.78 | 0.396 | 100.87 | 9.06 | 7.62 | 0.7282 | 10.14 | 5.30 | 8.13 |
| Koninklijke Philips NV | 19.48bn | 1.19bn | 36.30bn | 80.50k | 31.09 | 2.86 | 13.99 | 1.86 | 1.30 | 1.28 | 21.31 | 14.14 | 0.7347 | 3.89 | 4.54 | 242,027.50 | 4.50 | 3.18 | 6.26 | 4.61 | 45.55 | 45.74 | 6.12 | 5.05 | 0.9582 | 20.23 | 0.3014 | 89.07 | 7.51 | -1.85 | -8.98 | 39.44 | 3.67 | -- |
| Siemens Healthineers AG | 14.80bn | 1.53bn | 39.35bn | 53.00k | 25.84 | 4.00 | 17.65 | 2.66 | 1.52 | 1.52 | 14.78 | 9.83 | 0.6958 | 4.19 | 4.62 | 284,692.30 | 7.27 | -- | 9.71 | -- | 39.39 | -- | 10.44 | -- | 0.925 | 54.73 | 0.0477 | -- | 8.11 | -- | 23.87 | -- | -- | -- |
| EssilorLuxottica SA | 15.01bn | 1.23bn | 56.99bn | 150.62k | 40.42 | 1.69 | 21.19 | 3.80 | 3.22 | 3.22 | 42.55 | 77.25 | 0.495 | 3.53 | 6.76 | 99,630.85 | 4.45 | 6.61 | 5.43 | 8.71 | 61.15 | 60.75 | 9.00 | 12.35 | 0.7337 | 20.52 | 0.1557 | 40.85 | 17.58 | 16.35 | 4.52 | 12.88 | 19.04 | 16.76 |
Data as of Feb 27 2020. Currency figures normalised to Royal Philips's reporting currency: Euro EUR
24.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Dec 2019 | 64.33m | 7.17% |
| The Vanguard Group, Inc.as of 31 Jan 2020 | 33.53m | 3.74% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2019 | 26.22m | 2.92% |
| Amundi Asset Management SA (Investment Management)as of 07 Oct 2019 | 22.18m | 2.47% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 17.07m | 1.90% |
| BlackRock Investment Management LLCas of 20 Feb 2020 | 16.07m | 1.79% |
| BlackRock Fund Advisorsas of 07 Feb 2020 | 13.56m | 1.51% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2019 | 11.77m | 1.31% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2019 | 9.09m | 1.01% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2019 | 8.12m | 0.91% |
More ▼
Data from 31 Dec 2018 - 31 Dec 2019Source: FactSet Research Systems Inc.
